Overview

Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
0
Participant gender:
All
Summary
The proposed study will be conducted to compare the efficacy of maintenance ECT (M-ECT) vs Clozapine in treatment resistant schizophrenia (TRS) in terms of change in psychopathology measures and cerebral hemodynamics.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
All India Institute of Medical Sciences, Bhubaneswar
Treatments:
Clozapine
Criteria
Inclusion Criteria:

- Patients clinically diagnosed with treatment-resistant schizophrenia (TRS) (TRRIP
consensus criteria).

- Patients aged 18-60 years of either sex.

- Patients giving voluntary written consent for participation in the study

Exclusion Criteria:

- Patient already on Clozapine or ECT.

- History of psychoactive substance abuse or dependence.

- Co-morbid psychiatric, major medical, or neurological disorders.

- History of organicity or significant head injury.

- Pacemaker or metal in any part of the body excluding the mouth.

- Pregnant and breastfeeding females.